Delivery Order SPE2DB24D2105-SPE2DB25FAQGA
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,684.94 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets in a 90-count quantity. This firm fixed-price contract, awarded on July 17, 2025, carries a ceiling value of $9,648.60 and is scheduled for ultimate completion by July 18, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $8,908.09 by the Defense Logistics Agency for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,488.53 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by August 12, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 19, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract value of $2,935.98. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a non-competitive, non-set-aside award. The delivery will be fulfilled at the company's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $21,746.49 by the Defense Logistics Agency on May 5, 2025, for the supply of Jardiance 25 mg tablets (90-count). This firm fixed price, non-set-aside contract is scheduled for completion by May 6, 2025, with performance occurring at the awardee's Conshohocken facility. The award represents a single delivery order under AmerisourceBergen's broader relationship with DLA for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 90-count bottles of Jardiance 10 mg tablets, valued at $22,225.71. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation and represents a continuation of the vendor's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $5,871.96. The order is classified as a Firm Fixed Price delivery order with an ultimate completion date of September 18, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,094.36 by the Defense Logistics Agency for the supply of Jardiance 25 mg tablets (90-count packages). The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is the...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQGADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $55,198.97 by the Defense Logistics Agency (DLA) for the supply of Jardiance 25 mg tablets (90-count packaging). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded through open competition. The ultimate completion date is September 23, 2025, with the award issued on September 22, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related healthcare supplies across multiple therapeutic domains. This delivery order for Jardiance, a diabetes medication, exemplifies the company's role in fulfilling federal medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's Troop Support division is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key vendor in the federal military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.2k | 9/22/25 |